» Authors » Roberto Ranza

Roberto Ranza

Explore the profile of Roberto Ranza including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 277
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
da Cruz Ribeiro E Souza E, da Silva Carneiro S, Yazbek M, de Cassia Menin R, Campanholo C, Carneiro J, et al.
Adv Rheumatol . 2020 Sep; 60(1):49. PMID: 32962756
Background: Psoriatic arthritis (PsA) is a chronic inflammatory disease of widely varying presentation, which determines functional and psychological impairment, with a high negative impact on patients' quality of life. Therefore,...
12.
Aletaha D, Husni M, Merola J, Ranza R, Bertheussen H, Lippe R, et al.
Patient Prefer Adherence . 2020 Jul; 14:949-961. PMID: 32606613
Objective: Qualitative research exploring patient preferences regarding the mode of treatment administration for psoriatic arthritis (PsA) is limited. We report patient preferences and their reasons across PsA treatment modes. Methods:...
13.
Alves N, Moreira T, Duarte Silva Malvino L, Rodrigues J, Ranza R, Araujo L, et al.
Dermatol Res Pract . 2020 May; 2020:7209518. PMID: 32411192
Psoriasis and psoriatic arthritis are chronic, relapsing, immune-based diseases. Psoriatic patients may have nail involvement in 50 to 80% of cases, and this may reach 85% in patients with joint...
14.
Markus J, Pinto R, Matoso A, Ranza R
Rev Assoc Med Bras (1992) . 2020 Mar; 66(1):48-54. PMID: 32130381
Introduction: Systemic sclerosis (SSC) is an autoimmune disorder that affects several organs of unknown etiology, characterized by vascular damage and fibrosis of the skin and organs. Among the organs involved...
15.
Cecconi M, Ranza R, Titton D, Moraes J, Bertolo M, Bianchi W, et al.
J Clin Rheumatol . 2020 Feb; 26(2):73-78. PMID: 32073519
Background: The safety profile of biologic drugs might present substantial regional differences. Since 2009, the Brazilian Society of Rheumatology has maintained BIOBADABRASIL (Brazilian Registry for Biologic Drugs), a registry for...
16.
Ranza R, de la Vega M, Laurindo I, Gomez M, Titton D, Kakehasi A, et al.
Clin Rheumatol . 2019 Apr; 38(8):2129-2139. PMID: 31016578
Objective: Most reports on serious infections (SI) in rheumatoid arthritis (RA) patients treated with biological disease-modifying antirheumatic drugs (bDMARDs) are from the USA and Western Europe. Data from other regions...
17.
Costa C, Goldenstein-Schainberg C, Carneiro S, Rodrigues J, Romiti R, Barros T, et al.
PLoS One . 2018 Oct; 13(10):e0205486. PMID: 30308020
Methods: 465 patients diagnosed with psoriasis (158 with psoriatic arthritis confirmed by a rheumatologist according to the CASPAR criteria and 307 without) were evaluated in dermatology clinics. We performed the...
18.
Domingues S, Goncalves F, Jorge M, Limongi J, Ranza R, Jorge P
Endocr Pract . 2017 Aug; 23(11):1304-1310. PMID: 28816533
Objective: Because routine investigations are necessary for the early detection of thyroid disease, this study aimed to assess the prevalence of autoimmune thyroid disease (ATD) and thyroid dysfunction (TD) in...
19.
Yonekura C, Oliveira R, Titton D, Ranza R, Ranzolin A, Hayata A, et al.
Rev Bras Reumatol Engl Ed . 2017 Jul; 57 Suppl 2:477-483. PMID: 28739353
Objectives: To assess the incidence of tuberculosis and to screen for latent tuberculosis infection among Brazilians with rheumatoid arthritis using biologics in clinical practice. Patients And Methods: This cohort study...
20.
Fafa B, Louzada-Junior P, Titton D, Zandonade E, Ranza R, Laurindo I, et al.
Clin Rheumatol . 2015 Apr; 34(5):921-7. PMID: 25851594
Treatment survival with biological therapy may be influenced by many factors, and it seems to be different among various rheumatic diseases and biological agents. The goal of the study was...